BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34059990)

  • 1. Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
    Peng X; Tian A; Li J; Mao Y; Jiang N; Li T; Mao X
    Dig Dis Sci; 2022 Jun; 67(6):2627-2636. PubMed ID: 34059990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of FibroTouch and six serological models for assessing the degree of liver fibrosis in patients with chronic hepatitis B].
    Zuo ZB; Cui HZ; Huang CX; Guo Y; Pan KR; Wang MC; Du W; Huang B; Xu AF
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):430-435. PubMed ID: 31357758
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study on FibroTouch and multi-parameter model for diagnosis of hepatic fibrosis in patients with chronic liver disease].
    Wang R; Ren W; Zhao S; Niu X; Tan P; Du H; Nan Y
    Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):265-9. PubMed ID: 26133817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
    Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
    J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
    Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic value of various noninvasive indexes in the diagnosis of chronic hepatic fibrosis.
    Yang XZ; Gen AW; Xian JC; Xiao L
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):479-485. PubMed ID: 29424906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on the diagnostic value of GP73 in liver fibrosis among patients with chronic liver disease].
    An XY; Qiao J; Hu LX; Wang RQ; Nan YM
    Zhonghua Nei Ke Za Zhi; 2023 Jan; 62(1):49-53. PubMed ID: 36631037
    [No Abstract]   [Full Text] [Related]  

  • 8. Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C.
    Ragazzo TG; Paranagua-Vezozzo D; Lima FR; de Campos Mazo DF; Pessoa MG; Oliveira CP; Alves VAF; Carrilho FJ
    Clinics (Sao Paulo); 2017 Oct; 72(9):516-525. PubMed ID: 29069254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study.
    Xu Y; Liu Y; Cao Z; Wang L; Li Z; Sheng Z; Cai W; Wang H; Bao S; Xie Q
    Dig Liver Dis; 2019 Sep; 51(9):1323-1329. PubMed ID: 30928419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the diagnostic value of transient elastography, APRI and FIB-4 for liver fibrosis in children with non-alcoholic fatty liver disease].
    He SL; Li SJ; Liu M; Ouyang WX; Chen WJ; Zheng X; Jiang T; Tan YF; Kang Z; Qin XM; Yu Y
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):81-86. PubMed ID: 35152674
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic of FibroTouch and six serological models in assessing the degree of liver fibrosis among patients with chronic hepatic disease: A single-center retrospective study.
    Zuo Z; Cui H; Wang M; Huang C; Wu J; Tao C; Li Z; Yang C; Pan K; Bao J; Liu S; Xu A
    PLoS One; 2022; 17(7):e0270512. PubMed ID: 35776774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
    Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
    World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Serum Biomarker Indices for Staging of Hepatic Fibrosis Before and After Venesection in Patients With Hemochromatosis Caused by Variants in HFE.
    Chin J; Powell LW; Ramm LE; Hartel GF; Olynyk JK; Ramm GA
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1459-1468.e5. PubMed ID: 32745684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.
    Zeng X; Xu C; He D; Li M; Zhang H; Wu Q; Xiang D; Wang Y
    Croat Med J; 2015 Jun; 56(3):272-9. PubMed ID: 26088852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
    Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
    J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of liver fibrosis by transient elastography and multi-parameters model in young children with chronic hepatitis B virus infection.
    Luo H; Peng S; Ouyang W; Tan Y; Jiang T; Tang L; Li S; Qiu J; Zhou C
    BMC Infect Dis; 2022 Feb; 22(1):160. PubMed ID: 35180839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
    Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
    Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging liver fibrosis in chronic hepatitis B with T
    Yang L; Ding Y; Rao S; Chen C; Wu L; Sheng R; Fu C; Zeng M
    J Magn Reson Imaging; 2017 Apr; 45(4):1186-1194. PubMed ID: 27563840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.